Click here to view original web page at cen.acs.org
Case Hogan, who has Hunter syndrome, is in a clinical study of an intrathecally-delivered enzyme therapy. Researchers have long been vexed by the brain’s ability to shut out drugs. Now, Denali Therapeutics is offering evidence in mice and monkeys that a new drug delivery system can successfully sneak large […]